Novartis’s NASH Chief: Our Strategy Is Combos With Tropifexor As ‘Backbone’

 
• By Sten Stovall
  
Liver
Novartis's NASH Chief Says Program is gradually growing • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category